Abstract
In mammals, vasopressin is known to be synthesized in the hypothalamus and released in the blood stream at the pituitary level. This neuropeptide is also synthesized and secreted by the adrenal medulla in many species including human. Moreover, agents like acetylcholine and corticotropin releasing factor stimulates its basal secretion. V1a vasopressin receptors are present in the adrenal cortex and are involved in steroids secretion (aldosterone in the zona glomerulosa and glucocorticoids in the zona fasciculata of some species). These receptors are coupled to phospholipase Cβ and to dihydropyridine-sensitive calcium channels via heterotrimeric G proteins differing by their sensitivities to pertussis toxin. The adrenal medulla, from many species, exhibits V1a vasopressin receptors. In rat adrenal medulla, functional Vlb vasopressin receptors could also be characterized. These receptors stimulate catecholamines secretion via activation of phospholipase Cβ and subsequent mobilization of intracellular calcium.
The adrenal medulla secretes AVP and exhibits functional vasopressin receptors. The adrenal cortex also possesses functional vasopressin receptors and is in contact with adrenal medulla via “medullary rays”. We may thus reasonably conclude that AVP physiologically regulates adrenal gland functions via autocrine/paracrine mechanisms.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jard S 1983 Vasopressin isoreceptors in mammals: relation to cyclic AMP-dependent and cyclic AMP independent transduction mechanisms. Curr Top Membr Transp 1: 225–285.
Guillon G 1989 Les récepteurs à la vasopressine, l’ocytocine et l’angiotensine II chez les mammifères. In: (eds) Ann. Endocrinol. Paris, 50 pp 425–433
Baylis P 1989 Vasopressin and its neurophysin. In: De Groot LI (eds) Endocrinology. W.B. Saundern Company, Philadelphia, 1 pp 213–219
Imbert-Teboul M, Chabardès D, Montaigut M, Clique A, Morel F 1978 Vasopressin-dependent adenylate cyclase in the rat kidney medulla: evidence for two separate sites of actions. Endocrinology 102: 1254–1261.
Nussdorfer G 1996 Paracrine control of adrenal cortical functions by medullary chromaffin cells. Pharmacol Reviews 48: 495–530.
Grazzini E, Loedboerer A, Perez-Martin A, Joubert D, Guillon G 1996 Molecular and functional characterization of V lb vasopressin receptor in rat adrenal medulla. Endocrinology 137: 3906–3914.
Guillon G, Trueba M, Joubert D, Grazzini E, Chouinard L, Côte M, Payet M, Manzoni O, Barberis C, Robert M, Gallo-Payet N 1995 Vasopressin stimulates steroid secretion in human adrenal glands. Endocrinology 136: 1225–1295.
Suda T, Tomori N, Tozana F, Mouri T, Demupa H, Shizume K 1984 Distribution and characterization of irCRF in human tissues. J Clin Endocrinol Metab 59: 861–867.
Grazzini E, Durroux T, Payet M, Bilodeau L, Gallo-Payet N, Guillon G 1996 Membrane-delimited G protein-mediated coupling between VIa vasopressin receptor and dihydropyridine binding sites in rat glomerulosa cells. Mol Phannacol 50: 1273–1283.
Hilton JG, 1960 Adrenocorticotropin action of antidiuretic hormone. Circulation 21: 1038–1047.
Payet N, Isler H 1976 Adrenal glomerulosa mitotic stimulation by posterior pituitary hormones. Cell Tiss Res 172: 93–101
Payet N, Lehoux J 1980 A comparative study of the role of vasopressin and ACTH in the regulation of growth and function of rat adrenal gland. J Steroid Biochem 12: 461–467.
Guillon G, Payet N 1986 Specific vasopressin binding to rat adrenal glomerulosa cells. Biochem J 235: 209.
Gallo-Payet N, Chouinard L, Balestre M, Guillon G 1991 Involvement of protein kinase C in the coupling between the VI vasopressin receptor and phospholipase C in rat glomerulosa cells. Endocrinology 129: 623–634.
Herlitze S, Garcia D, Macki K, Hille B, Scheuer T, Caterall W 1996 Modulation of Ca++ channels by G-protein 13y subunits. Nature 380: 258–262.
Drolet P, Bilodeau L, Charvatova A, Laflamme L, Gallo-Payet N, Payet MD 1997 Inhibition of the T-type calcium current by the dopamine D1 receptor in rat glomerulosa cells: requirement of combined action of GP protein subunit and cyclic adenosine 3'-5'monophosphate. Mol Endocrinol 11: 503–514.
Perraudin V, Delarue C, Lefèvre H, Comtesse V, Kuhn V, Vaudry H 1993 Vasopressin stimulates cortisol secretion from human adrenocortical tissue through activation of VI vasopressin receptor. J Clin Endocrinol Metab 76: 1522–1528.
Bird I, Nicol M, Williams B, Walker S 1990 Vasopressin stimulates cortisol secretion and phosphoinositol metabolism in cultured bovine adrenal fasciculata/reticularis cells. J Mol Endocrinol 5: 109–116.
Schneider E 1988 Effect of vasopressin on adrenal steroidogenesis. Am J Physiol 255: R806--R811.
Mazzochi G, Markowska A, Malendowicz L, Nusato F, Meneghelli V, Nussdorfer G 1993 Evidence that endogenous AVP is involved in the maintenance of growth and steroidogenic capacity of rat adrenal zona glomerulosa. J Steroid Biochem Mol Biol 45: 251–256.
Mazzocchi G, Malendowicz LK, Meneghelli V, Gottardo G, Nussdorfer GG 1995 In vitro and in vivo studies of the effects of AVP on the secretion and growth of rat adrenal cortex. Histol Histopathol 10: 359–370.
Guillon G, Balestre M, Chouinard L, Gallo-Payet N 1990 Involvement of distinct G proteins in the action of vasopressin on rat glomerulosa cells. Endocrinology 125: 1699–1708.
Antoni F 1984 Characterization of high affinity binding sites for vasopressin in bovine adrenal medulla. Neuropeptides 4: 413–420.
Taylor AH, Whitley G, St J, Nussey SS 1989 The interaction of AVP and OT with bovine adrenal medulla cells. J of Endocrinology 121: 133–139.
Schwartz J, Derdowska I, Sobocinska M, Kuprysensky G 1991 A potent new synthetic analog of vasopressin with relative agonist specificity for the pituitary. Endocrinology 129: 1107–1109.
Serradeil-Le Gal C, Wagnon J, Garcia C, Lacour C, Guiraudou P, Christophe B, Villanova G, Nizato D, Maffrand J, Le Fur G, Guillon G, Cantau B, Barberis C, Trueba M, Ala Y, Jard S 1993 Biochemical and pharmacological properties of SR 49059, a new potent non-peptide antagonist in rat and human vasopressin Vla receptor. J Clin Invest 92: 224–231.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Grazzini, E. et al. (1998). Vasopressin Regulates Adrenal Functions by Acting through Different Vasopressin Receptor Subtypes. In: Zingg, H.H., Bourque, C.W., Bichet, D.G. (eds) Vasopressin and Oxytocin. Advances in Experimental Medicine and Biology, vol 449. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4871-3_41
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4871-3_41
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7210-3
Online ISBN: 978-1-4615-4871-3
eBook Packages: Springer Book Archive